Concert Pharmaceuticals

Manufacturing · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

65 Hayden Ave Ste 3000N, Lexington, Mass...

Phone Number

(781) 860-0045

Revenue

$32.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Concert Pharmaceuticals

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to treat serious diseases and address unmet patient needs. The Company's approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert's pipeline of innovative medicines targets autoimmune diseases and central nervous systems (CNS) disorders.Explore more
Concert Pharmaceuticals's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Concert Pharmaceuticals Org Chart

PhoneEmail
JL
United States flag for contact location.

DIrector, DMPK

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Concert Pharmaceuticals

Compare insights from companies similar to Concert Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Concert Pharmaceuticals

$32.6M
51-200
Private
$278.5M
2006
JL
Janice LauDIrector, DMPK
$276.8M
51-200
Public
$888.4M
1996
EM
Esteban MasudaHead Executive VP, Research
$274.5M
11-50
Public
$6M
1987
Tavo Espinoza, Chief Financial Officer at Ligand Pharmaceuticals
Tavo EspinozaChief Financial Officer
$69.2M
51-200
Public
$191M
1995
Tara Kieffer, Chief Operating Officer at Enanta Pharmaceuticals
Tara KiefferChief Operating Officer
$40.9M
11-50
Public
-
2000
Tom Bures, Senior VP & Chief Financial Officer at Pieris Pharmaceuticals
Tom BuresSenior VP & Chief Financial Officer
$13.9M
51-200
Private
$40M
2005
N/A
$13.4M
51-200
Private
-
2000
MR
Marie RyderSenior Research Associate
Illustration of an envelope

Concert Pharmaceuticals Tech Stack

A closer look at the technologies used by Concert Pharmaceuticals

Top Manufacturing Companies

Frequently Asked Questions Regarding Concert Pharmaceuticals

What is Concert Pharmaceuticals's official website?
Concert Pharmaceuticals's official website is www.concertpharma.com
What is Concert Pharmaceuticals's Revenue?
Concert Pharmaceuticals's revenue is $32.6 Million
What is Concert Pharmaceuticals's SIC code?
Concert Pharmaceuticals's SIC: 87,873
What is Concert Pharmaceuticals's NAICS code?
Concert Pharmaceuticals's NAICS: 54,541
How many employees does Concert Pharmaceuticals have?
Concert Pharmaceuticals has 51-200 employees
What industry does Concert Pharmaceuticals belong to?
Concert Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Concert Pharmaceuticals competition?
Concert Pharmaceuticals top competitors include: Rigel, Ligand Pharmaceuticals, Enanta Pharmaceuticals, Pieris Pharmaceuticals
What companies has Concert Pharmaceuticals acquired?
Concert Pharmaceuticals has acquired the companies: Concert Pharmaceuticals, PENN Entertainment, Ameristar Casinos, Pinnacle Entertainment
What technology does Concert Pharmaceuticals use?
Some of the popular technologies that Concert Pharmaceuticals uses are: Microsoft IIS, WordPress.org, PHP, Google Cloud Web Serving
How do I contact Concert Pharmaceuticals?
Concert Pharmaceuticals contact info: Phone number: (781) 860-0045 Website: www.concertpharma.com
What does Concert Pharmaceuticals do?

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to treat serious diseases and address unmet patient needs. The Company's approach starts with previously studied compounds, including approved drugs, in which deuterium... substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert's pipeline of innovative medicines targets autoimmune diseases and central nervous systems (CNS) disorders.Read More

What are Concert Pharmaceuticals social media links?
Concert Pharmaceuticals Linkedin page Concert Pharmaceuticals Twitter page
Who invested in Concert Pharmaceuticals?
Concert Pharmaceuticals has 29 investors including QVT Fund, Greylock Partners, TVM Capital and Skyline Ventures.
Is Concert Pharmaceuticals a public company?
Concert Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Concert Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.